The research centre is gearing up to be the nerve centre for pharma research in India. Launched in April this year, the research centre is catering to some of the top names in the pharma industry in India, working on to improve the efficacy of poorly soluble drugs and increasing use of controlled-release technology. The new pharmaceutical centre of excellence in Hyderabad, is a state-of-the-art facility specialising in oral solid-dosage form research.
In addition to developing innovative and need-based solutions for the customers, Ashland team at Hyderabad also provides customised training on product applications and technical assistance as per specific requests from customers. Superior technical service forms an important part of the offering and distinguishes Ashland from others.
‘Training to distributors’ is an initiative to reach out to the very crucial community that actually drives the market activity. Recently, the Centre conducted two training programmes for pharma industry distributors. One for Indian distributors and another for rest of Asia channel partners. The training, as an educational seminar, highlighted pharma core application areas – tablet binders, disintegrants, controlled release solubilisation and film coating. The distributors toured around the centre of excellence and were also given opportunities for hands-on laboratory training. The training demonstrated ASI’s commitment to expand its presence in Asia.
Tom Durig, Senior Director, Global pharmaceutical R&D, Ashland Speciality Ingredients said, “Our ability to drive meaningful innovation- from creation of new chemistries to enhanced formulations for existing products allows us to deliver highly tailored customer solutions.” Research taking place at Ashland today will form the basis of new technical solutions that further address formulation and manufacturing challenges.
EP News Bureau – Mumbai